ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ILMN Illumina Inc

106.27
0.42 (0.40%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,086,822
Bid Price 104.00
Ask Price 108.34
News -
Day High 107.25

Low
89.00

52 Week Range

High
213.91

Day Low 104.34
Company Name Stock Ticker Symbol Market Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.42 0.40% 106.27 20:00:00
Open Price Low Price High Price Close Price Prev Close
106.69 104.34 107.25 106.48 105.85
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
26,423 1,086,822 $ 105.95 $ 115,149,758 - 89.00 - 213.91
Last Trade Time Type Quantity Stock Price Currency
19:42:22 20 $ 106.48 USD

Illumina (ILMN) Options Flow Summary

Overall Flow

Bullish

Net Premium

41k

Calls / Puts

60.00%

Buys / Sells

700.00%

OTM / ITM

300.00%

Sweeps Ratio

0.00%

Illumina Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
16.92B 158.90M - 4.5B -1.16B -7.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Illumina News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ILMN Message Board. Create One! See More Posts on ILMN Message Board See More Message Board Posts

Historical ILMN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week113.84113.84104.34107.891,615,458-7.57-6.65%
1 Month119.65127.745104.34114.311,666,644-13.38-11.18%
3 Months139.20144.1899104.34124.401,603,022-32.93-23.66%
6 Months97.00148.1993.51127.801,904,4559.279.56%
1 Year201.93213.9189.00139.091,903,533-95.66-47.37%
3 Years403.04526.0089.00213.251,395,717-296.77-73.63%
5 Years311.64555.7789.00254.971,287,581-205.37-65.90%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Your Recent History

Delayed Upgrade Clock